Karen Katen recently retired as Vice Chairman of Pfizer, Inc. and as President of Pfizer Human Health – the company’s principal operating group, responsible for the discovery, development, manufacture, distribution and commercialization of prescription medicines, as well as for providing a broad array of innovative human-health services. The Human Health organization -- represented by over 90,000 colleagues -- generated 2006 revenues exceeding $45 billion and had an industry-leading portfolio comprising three of the world's 25 top-selling medicines and seven therapeutic-area leaders. Ms. Katen's career at Pfizer, Inc. spanned 33 years.
Ms. Katen's achievements have received wide recognition. In 2005, Karen was named among the top ten in Fortune Magazine’s ranking of “50 Most Powerful Women in Business,” a list that included her for eight consecutive years. For her commitment to community and improving public health, she has received eleven distinct “Woman of the Year” or similar awards from civic groups, national associations and universities.
Ms. Katen joined EWHV in October 2007 as a Senior Advisor to the New York office. She is a director on the boards of the Harris Corporation, The Home Depot, Air Liquide, and the Takeda Global Advisory Board. She also serves on the Catalyst Board, the RAND Corporation’s Health Board of Advisors, ARMGO Pharmaceutical's Board and the Economic Club of New York Board of Trustees. She has served as chairman of the Pfizer Foundation, as well as on the board of the General Motors Corporation. Ms. Katen holds a B.A. and M.B.A. from the University of Chicago, where she now serves as a University Trustee and a council member of its Booth School of Business.
|
